The Rise of Single-Use Bioprocessing
A Market on the Verge of Explosion
A Look at the Future of Pharmaceutical Manufacturing
The global single-use bioprocessing market is on the cusp of a major expansion. Valued at USD 161 billion in 2023, the market is projected to reach a staggering USD 645 billion by 2029, according to a recent report by IMARC Group. This unprecedented growth is driven by several factors:
- Increasing demand for cost-effective manufacturing processes
- Growing adoption of single-use technologies in pharmaceutical and biotechnology industries
- Expansion of the disposable income in developing countries
- Rising prevalence of chronic diseases, leading to increased demand for biologics
Comments